Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial
- PMID: 18687718
- PMCID: PMC2505091
- DOI: 10.1136/bmj.a716
Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial
Abstract
Objective: To compare the effectiveness of clomifene citrate and unstimulated intrauterine insemination with expectant management for the treatment of unexplained infertility.
Design: Three arm parallel group, pragmatic randomised controlled trial.
Setting: Four teaching hospitals and a district general hospital in Scotland.
Participants: Couples with infertility for over two years, confirmed ovulation, patent fallopian tubes, and motile sperm.
Intervention: Expectant management, oral clomifene citrate, and unstimulated intrauterine insemination.
Main outcome measures: The primary outcome was live birth. Secondary outcome measures included clinical pregnancy, multiple pregnancy, miscarriage, and acceptability.
Results: 580 women were randomised to expectant management (n=193), oral clomifene citrate (n=194), or unstimulated intrauterine insemination (n=193) for six months. The three randomised groups were comparable in terms of age, body mass index, duration of infertility, sperm concentration, and motility. Live birth rates were 32/193 (17%), 26/192 (14%), and 43/191 (23%), respectively. Compared with expectant management, the odds ratio for a live birth was 0.79 (95% confidence interval 0.45 to 1.38) after clomifene citrate and 1.46 (0.88 to 2.43) after unstimulated intrauterine insemination. More women randomised to clomifene citrate (159/170, 94%) and unstimulated intrauterine insemination (155/162, 96%) found the process of treatment acceptable than those randomised to expectant management (123/153, 80%) (P=0.001 and P<0.001, respectively).
Conclusion: In couples with unexplained infertility existing treatments such as empirical clomifene and unstimulated intrauterine insemination are unlikely to offer superior live birth rates compared with expectant management.
Trial registration: ISRCT No: 71762042.
Conflict of interest statement
Competing interests: None declared.
Figures


Comment in
-
Treatment of unexplained infertility.BMJ. 2008 Aug 7;337:a772. doi: 10.1136/bmj.a772. BMJ. 2008. PMID: 18687719 No abstract available.
References
-
- Templeton A. Infertility-epidemiology, aetiology, and effective management. Health Bull Edinb 1995;53:294-8. - PubMed
-
- Collins JA, Burrows EA, Wilan AR. The prognosis for live birth among untreated infertile couples. Fertil Steril 1995;64:22-8. - PubMed
-
- Royal College of Obstetricians and Gynaecologists. The management of infertility in secondary care: evidence-based guidelines. No 3. London: RCOG, 1998.
-
- Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril 1998;70:207-13. - PubMed
-
- Practice Committee of the American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertil Steril 2006;86:S1111. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical